27 Aug |
2021 Interim Results Announcement |
N/A |
28 May |
2021 Annual General Meeting |
|
30 Mar |
2020 Annual Results Announcement |
N/A |
05 Feb |
Clinical trial approval for Foracin™ obtained in China by Wanbang Biopharmaceutical Group Co., Ltd. from the Centre of Drug Evaluation |
N/A |
18 Jan |
Announcement of the launch by Orient EuroPharma Co., Ltd. of Fortacin™ for sale in Hong Kong in January and the expected launch of Fortacin™ in Macau in March 2021 and in Taiwan in April 2021 |
N/A |